The Annals of Pharmacy Education, Safety, and Public Health Advocacy is dedicated exclusively to the field of clinical oncology, with a broad yet rigorous scope that encompasses all facets of cancer research directly impacting patient care. The journal invites original research articles, systematic reviews, meta-analyses, short communications, and case reports that contribute to the advancement of knowledge and clinical practice in oncology.
Key areas:
- Clinical Trials: Design, execution, and analysis of phase I–IV clinical trials evaluating novel diagnostic techniques, therapeutic interventions, and supportive care strategies.
- Cancer Diagnosis & Screening: Development and validation of innovative diagnostic tools, biomarkers, imaging modalities, and screening programs aimed at early detection and accurate staging of malignancies.
- Treatment Strategies: Research on surgical techniques, radiotherapy, chemotherapy, immunotherapy, targeted therapy, and emerging personalized treatment modalities.
- Cancer Biology & Translational Research: Studies bridging laboratory findings with clinical application, including tumor biology, molecular genetics, and immunopathology with direct clinical implications.
- Prognosis & Outcomes Research: Investigations into prognostic factors, risk stratification, and survival outcomes that inform treatment decisions and patient counseling.
- Supportive & Palliative Care: Research focused on improving quality of life, symptom management, survivorship, and palliative interventions for patients at all stages of cancer.
- Epidemiology & Public Health: Population-based studies on cancer incidence, prevalence, risk factors, and preventive measures relevant to the Asian region and beyond.
- Ethics, Policy & Health Systems: Articles addressing the ethical, regulatory, economic, and policy aspects of cancer care delivery and clinical research.
By embracing diverse research methodologies and interdisciplinary approaches, the Annals of Pharmacy Education, Safety, and Public Health Advocacy strives to be a vital resource for clinicians, researchers, oncologists, surgeons, radiologists, pathologists, and allied health professionals. Our ultimate goal is to encourage scholarly dialogue and collaboration that translate into tangible improvements in the prevention, diagnosis, and treatment of cancer.
